Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in Chronic Kidney Disease (CKD Dragon-Registry). [PDF]
Januszek R +26 more
europepmc +1 more source
Immunosuppressive therapy and tolerance of organ allografts [PDF]
Starzl, TE
core +1 more source
Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial. [PDF]
Wang P +26 more
europepmc +1 more source
Impact of Nonadherence to Any Antiplatelet Therapy After PCI With Drug-Eluting Stents on Critical Outcomes. [PDF]
Mori Y +4 more
europepmc +1 more source
Drug-eluting stents from cardiology to pneumonology. [PDF]
Zarogoulidis P, Huang H, Freitag L.
europepmc +1 more source
Introducing and utilizing innovative technologies in health care systems: a country comparison for peripheral drug-eluting stents in Germany and the USA. [PDF]
Felgner S +4 more
europepmc +1 more source
One-Year Outcomes of Short-Term Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials. [PDF]
Fretz T +10 more
europepmc +1 more source
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial. [PDF]
Han JK +20 more
europepmc +1 more source

